{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:23:12Z","timestamp":1792603392404,"version":"4.5.0"},"reference-count":79,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["22-13-00036"],"award-info":[{"award-number":["22-13-00036"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Sulfonamides are the basic motifs for a whole generation of drugs from a large group of antibiotics. Currently, research in the field of the new sulfonamide synthesis has received a \u201csecond wind\u201d, due to the increase in the synthetic capabilities of organic chemistry and the study of their medical and biological properties of a wide spectrum of biological activity. New reagents and new reactions make it possible to significantly increase the number of compounds with a sulfonamide fragment in combination with other important pharmacophore groups, such as, for example, a wide class of N-containing heterocycles. The result of these synthetic possibilities is the extension of the activity spectrum\u2014along with antibacterial activity, many of them exhibit other types of biological activity. Antiviral activity is also observed in a wide range of sulfonamide derivatives. This review provides examples of the synthesis of sulfonamide compounds with antiviral properties that can be used to develop drugs against coxsackievirus B, enteroviruses, encephalomyocarditis viruses, adenoviruses, human parainfluenza viruses, Ebola virus, Marburg virus, SARS-CoV-2, HIV and others. Since over the past three years, viral infections have become a special problem for public health throughout the world, the development of new broad-spectrum antiviral drugs is an extremely important task for synthetic organic and medicinal chemistry. Sulfonamides can be both sources of nitrogen for building a nitrogen-containing heterocyclic core and the side chain substituents of a biologically active substance. The formation of the sulfonamide group is often achieved by the reaction of the N-nucleophilic center in the substrate molecule with the corresponding sulfonylchloride. Another approach involves the use of sulfonamides as the reagents for building a nitrogen-containing framework.<\/jats:p>","DOI":"10.3390\/molecules28010051","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T06:11:24Z","timestamp":1671603084000},"page":"51","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Sulfonamides with Heterocyclic Periphery as Antiviral Agents"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9460-3413","authenticated-orcid":false,"given":"Mikhail Yu.","family":"Moskalik","sequence":"first","affiliation":[{"name":"Irkutsk Institute of Chemistry, Siberian Branch of the Russian Academy of Sciences, 1 Favorsky Street, 664033 Irkutsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"Sulfonamides: Historical Discovery Development (Structure-Activity Relationship Notes)","volume":"1","author":"Mansour","year":"2018","journal-title":"Vitr. -Vivo -Silico J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2174\/0929867033457647","article-title":"Anticancer and Antiviral Sulfonamides","volume":"10","author":"Scozzafava","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1002\/anie.201610456","article-title":"Sulfonimidamides in Medicinal and Agricultural Chemistry","volume":"56","author":"Chinthakindi","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.bioorg.2018.09.021","article-title":"Rational design and synthesis of new tetralin-sulfonamide derivatives as potent anti-diabetics and DPP-4 inhibitors: 2D & 3D QSAR, in vivo radiolabeling and bio distribution studies","volume":"81","author":"Anwar","year":"2018","journal-title":"Bioorg. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"112019","DOI":"10.1016\/j.ejmech.2019.112019","article-title":"Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation","volume":"189","author":"Said","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"8459","DOI":"10.1021\/acs.jafc.9b02681","article-title":"Synthesis, Antiviral Activity, and Mechanisms of Purine Nucleoside Derivatives Containing a Sulfonamide Moiety","volume":"67","author":"He","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"12126","DOI":"10.1021\/acs.jafc.1c02467","article-title":"Discovery of Novel Chromone Derivatives Containing a Sulfonamide Moiety as Anti-ToCV Agents through the Tomato Chlorosis Virus Coat Protein-Oriented Screening Method","volume":"69","author":"Jiang","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"100077","DOI":"10.1016\/j.medidd.2020.100077","article-title":"AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate","volume":"9","author":"Delijewski","year":"2021","journal-title":"Med. Drug Discov."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"10951","DOI":"10.1021\/acs.jmedchem.1c00304","article-title":"Aryl Sulfonamide Inhibits Entry and Replication of Diverse Influenza Viruses via the Hemagglutinin Protein","volume":"64","author":"White","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2146\/ajhp170279","article-title":"Evaluating off-label uses of acetazolamide","volume":"75","author":"Elefritz","year":"2018","journal-title":"Am. J. Health-Sys. Pharm."},{"key":"ref_11","first-page":"13995","article-title":"Synthesis, Docking and Antihypertensive Activity of Pyridone Derivatives","volume":"5","author":"Masaret","year":"2020","journal-title":"Chem. Select"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Dolensky, J., Hinteregger, C., Leitner, A., Seebacher, W., Saf, R., Belaj, F., M\u00e4ser, P., Kaiser, M., and Weis, R. (2022). Antiprotozoal Activity of Azabicyclo-Nonanes Linked to Tetrazole or Sulfonamide Cores. Molecules, 27.","DOI":"10.3390\/molecules27196217"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2174\/1385272822666180122153839","article-title":"Sulfonamides as potential bioactive scaffolds","volume":"22","author":"Khan","year":"2018","journal-title":"Curr. Org. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"113837","DOI":"10.1016\/j.ejmech.2021.113837","article-title":"Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation","volume":"226","author":"Wan","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bioorg.2018.01.021","article-title":"New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors","volume":"77","author":"Gul","year":"2018","journal-title":"Bioorg. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"103711","DOI":"10.1016\/j.bioorg.2020.103711","article-title":"Design, synthesis and biological evaluation of novel 5,6,7-trimethoxy-N-aryl-2-styrylquinolin-4-amines as potential anticancer agents and tubulin polymerization inhibitors","volume":"98","author":"Mirzaei","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bioorg.2018.11.033","article-title":"Synthesis and anti-inflammatory activity of sulfonamides and carboxylates incorporating trimellitimides: Dual cyclooxygenase\/carbonic anhydrase inhibitory actions","volume":"84","author":"Angeli","year":"2019","journal-title":"Bioorg. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"133672","DOI":"10.1016\/j.molstruc.2022.133672","article-title":"Sulfonamide diuretic azosemide as an efficient carbonic anhydrase inhibitor","volume":"1268","author":"Ferraroni","year":"2022","journal-title":"J. Mol. Struct."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acs.jmedchem.7b01086","article-title":"The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity","volume":"61","author":"Brus","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"126677","DOI":"10.1016\/j.bmcl.2019.126677","article-title":"1,3,4-Oxadiazol-2-ylbenzenesulfonamides as privileged structures for the inhibition of monoamine oxidase B","volume":"29","author":"Shetnev","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2014.07.023","article-title":"Potent, orally available, selective COX-2 inhibitors based on 2-imidazoline core","volume":"84","author":"Sarnpitak","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kalinin, S., Malkova, A., Sharonova, T., Sharoyko, V., Bunev, A., Supuran, C.T., and Krasavin, M. (2021). Carbonic Anhydrase IX Inhibitors as Candidates for Combination Therapy of Solid Tumors. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413405"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"111642","DOI":"10.1016\/j.ejmech.2019.111642","article-title":"From random to rational: A discovery approach to selective subnanomolar inhibitors of human carbonic anhydrase IV based on the Castagnoli-Cushman multicomponent reaction","volume":"182","author":"Kalinin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/14756366.2021.1927007","article-title":"Biochemical profiling of anti-HIV prodrug Elsulfavirine (Elpida\u00ae) and its active form VM1500A against a panel of twelve human carbonic anhydrase isoforms","volume":"36","author":"Supuran","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejmech.2015.06.022","article-title":"Probing the \u2018bipolar\u2019 nature of the carbonic anhydrase active site: Aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms","volume":"101","author":"Krasavin","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/14756366.2022.2056733","article-title":"5-(Sulfamoyl)thien-2-yl 1,3-oxazole inhibitors of carbonic anhydrase II with hydrophilic periphery","volume":"37","author":"Kalinin","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1515\/pac-2018-1219","article-title":"Oxidative sulfamidation as a route to N-heterocycles and unsaturated sulfonamides","volume":"92","author":"Moskalik","year":"2019","journal-title":"Pure Appl. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1248\/cpb.56.1367","article-title":"Development of new synthetic reactions for nitrogen-containing compounds and their application","volume":"56","author":"Naito","year":"2008","journal-title":"Chem. Pharm. Bull."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kerru, N., Gummidi, L., Maddila, S., Gangu, K.K., and Jonnalagadda, S.B. (2020). A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications. Molecules, 25.","DOI":"10.3390\/molecules25081909"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"113473","DOI":"10.1016\/j.biopha.2022.113473","article-title":"Chiral sulfonamides with various N-heterocyclic and aromatic units\u2014Synthesis and antiviral activity evaluation","volume":"153","author":"Iwan","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1016\/j.tet.2012.07.028","article-title":"Novel chiral bridged azepanes: Stereoselective ring expansion of 2-azanorbornan-3-yl methanols","volume":"68","year":"2012","journal-title":"Tetrahedron"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s11172-019-2517-0","article-title":"Synthesis of (1S)-(+)-camphor-10-sulfonic acid derivatives and investigations in vitro and in silico of their antiviral activity as the inhibitors of fi lovirus infections","volume":"68","author":"Sokolova","year":"2019","journal-title":"Russ. Chem. Bull."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1039\/C7MD00424A","article-title":"N-Heterocyclic borneol derivatives as inhibitors of Marburg virus glycoprotein-mediated VSIV pseudotype entry","volume":"8","author":"Kononova","year":"2017","journal-title":"Med. Chem. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00044-017-2077-5","article-title":"Synthesis and antiviral study of 4-(7,7-dimethyl-4-(piperazin-1-yl)-5,6,7,8-tetrahydroquinazolin-2-yl) morpholine derivatives","volume":"27","author":"Selvakumar","year":"2018","journal-title":"Med. Chem. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1248\/cpb.29.948","article-title":"Pyrimidine Derivatives. II. New Synthesis and Reactions of 4-Amino-2-methylthiopyrimidine Derivatives","volume":"29","author":"Sekiya","year":"1981","journal-title":"Chem. Pharm. Bull."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.bmcl.2010.01.131","article-title":"Rigidified 2-aminopyrimidines as histamine H4 receptor antagonists: Effects of substitution about the rigidifying ring","volume":"20","author":"Koenig","year":"2010","journal-title":"Biorg. Med. Chem. Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/S0960-894X(03)00634-6","article-title":"Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. Part 4: Structure\u2013activity relationships for substituents on the quinazoline moiety of 4-[4-(N-substituted(thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives","volume":"13","author":"Matsuno","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.24820\/ark.5550190.p010.037","article-title":"Synthesis and antiviral activity of 4-(7,7-dimethyl-4-[4-{N-aroyl\/benzyl}1-piperazinyl]-5,6,7,8-tetrahydroquinazolin-2-yl)morpholine derivatives","volume":"2017","author":"Selvakumar","year":"2017","journal-title":"Arkivoc"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"127667","DOI":"10.1016\/j.bmcl.2020.127667","article-title":"Discovery of cyclic sulfonamide derivatives as potent inhibitors of SARS-CoV-2","volume":"31","author":"Shin","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.0105-1873.2006.00735.x","article-title":"Characterization and chemistry of imidazolidinyl urea and diazolidinyl urea","volume":"54","author":"Lehmann","year":"2006","journal-title":"Contact Dermat."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1021\/np900437y","article-title":"Parazoanthines A\u2212E, Hydantoin Alkaloids from the Mediterranean Sea Anemone Parazoanthus axinellae","volume":"72","author":"Cachet","year":"2009","journal-title":"J. Nat. Prod."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/00304940409356627","article-title":"Recent Developments in Hydantoin Chemistry. A Review","volume":"36","author":"Meusel","year":"2004","journal-title":"Org. Prep. Proced. Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejmech.2018.12.066","article-title":"Recent applications of hydantoin and thiohydantoin in medicinal chemistry","volume":"164","author":"Cho","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e1900391","DOI":"10.1002\/cbdv.201900391","article-title":"New 2-Oxoimidazolidine Derivatives: Design, Synthesis and Evaluation of Anti-BK Virus Activities in Vitro","volume":"16","author":"Kornii","year":"2019","journal-title":"Chem. Biodivers."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.15407\/bioorganica2021.01.010","article-title":"New 4-iminohydantoin sulfamide derivatives with antiviral and anticancer activity","volume":"16","author":"Kornii","year":"2021","journal-title":"Ukr. Bioorg. Acta"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"132600","DOI":"10.1016\/j.molstruc.2022.132600","article-title":"Synthesis, characterization, molecular modeling against EGFR target and ADME\/T analysis of novel purine derivatives of sulfonamides","volume":"1257","author":"Bhat","year":"2022","journal-title":"J. Mol. Struct."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/095632029100200601","article-title":"Didanosine","volume":"2","author":"McLaren","year":"1991","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2006.03.007","article-title":"Synthesis and antiviral evaluation of alkoxyalkyl esters of acyclic purine and pyrimidine nucleoside phosphonates against HIV-1 in vitro","volume":"72","author":"Valiaeva","year":"2006","journal-title":"Antivir. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1021\/jm980651u","article-title":"Synthesis and anti-HIV and anti-HBV activities of 2\u2019-fluoro-2\u2019,3\u2019- unsaturated L-nucleosides","volume":"42","author":"Lee","year":"1999","journal-title":"J. Med. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejphar.2005.11.037","article-title":"Purine P1 receptor-dependent immunostimulatory effects of antiviral acyclic analogues of adenine and 2,6-diaminopurine","volume":"530","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/15257770600793919","article-title":"Synthesis of 2-Bromomethyl-3-Hydroxy-2-Hydroxymethyl-Propyl Pyrimidine and Theophylline Nucleosides Under Microwave Irradiation. Evaluation of Their Activity Against Hepatitis B Virus","volume":"25","author":"Ashry","year":"2006","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1021\/jm060711t","article-title":"Synthesis from Caffeine of a Mixed N-Heterocyclic Carbene\u2212Silver Acetate Complex Active against Resistant Respiratory Pathogens","volume":"49","author":"Melaiye","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"132830","DOI":"10.1016\/j.tet.2022.132830","article-title":"Late-stage sulfonic acid\/sulfonate formation from sulfonamides via sulfonyl pyrroles","volume":"117\u2013118","author":"Ozaki","year":"2022","journal-title":"Tetrahedron"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"18235","DOI":"10.1002\/anie.201910895","article-title":"Selective Late-Stage Sulfonyl Chloride Formation from Sulfonamides Enabled by Pyry-BF4","volume":"58","author":"Cornella","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Famiglini, V., Castellano, S., and Silvestri, R. (2017). N-Pyrrylarylsulfones with High Therapeutic Potential. Molecules, 22.","DOI":"10.3390\/molecules22030434"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"105313","DOI":"10.1016\/j.bioorg.2021.105313","article-title":"Design, synthesis, and evaluation of HIV-1 entry inhibitors based on broadly neutralizing antibody 447-52D and gp120 V3loop interactions","volume":"116","author":"Senapathi","year":"2021","journal-title":"Bioorg. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1021\/acsmedchemlett.8b00583","article-title":"Scaffold Morphing Approach To Expand the Toolbox of Broad-Spectrum Antivirals Blocking Dengue\/Zika Replication","volume":"10","author":"Vincetti","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"104855","DOI":"10.1016\/j.antiviral.2020.104855","article-title":"7-Deaza-7-fluoro-2\u2032-C-methyladenosine inhibits Zika virus infection and viral-induced neuroinflammation","volume":"180","author":"Rocha","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.ejmech.2011.02.014","article-title":"Broad-spectrum antiviral activity including human immunodeficiency and hepatitis C viruses mediated by a novel retinoid thiosemicarbazone derivative","volume":"46","author":"Kesel","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1080\/00397911.2019.1626893","article-title":"Efficient synthesis and anti-bovine viral diarrhea virus evaluation of 5-(aryldiazo)salicylaldehyde thiosemicarbazone derivatives","volume":"49","author":"Abbas","year":"2019","journal-title":"Synth. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1016\/j.bmc.2017.05.056","article-title":"Synthesis, antiviral evaluation and molecular docking studies of N4-aryl substituted\/unsubstituted thiosemicarbazones derived from 1-indanones as potent anti-bovine viral diarrhea virus agents","volume":"25","author":"Fabiani","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1080\/00397911.2021.1925298","article-title":"Synthesis and antiviral evaluation of 5-(arylazo)salicylaldehyde thiosemicarbazone derivatives as potent anti-bovine viral diarrhea virus agents","volume":"51","author":"Basyouni","year":"2021","journal-title":"Synth. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.bmc.2017.12.033","article-title":"Structural optimization of N1-aryl-benzimidazoles for the discovery of new non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains","volume":"26","author":"Monforte","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.4314\/tjpr.v17i9.25","article-title":"Synthesis of new quinoline scaffolds via a solvent-free fusion method and their anti-microbial properties","volume":"17","author":"Mubeen","year":"2018","journal-title":"Tropical J. Pharm. Res."},{"key":"ref_65","first-page":"455","article-title":"Quinolones: A Comprehensive Review","volume":"65","author":"Oliphant","year":"2002","journal-title":"Am. Fam. Physician"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"8933","DOI":"10.1016\/S0040-4020(01)91215-3","article-title":"Calixarenes\u2014The third generation of supramolecules","volume":"49","author":"Shinkai","year":"1993","journal-title":"Tetrahedron"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.2147\/DDDT.S83213","article-title":"Applications of calixarenes in cancer chemotherapy: Facts and perspectives","volume":"9","author":"Hamid","year":"2015","journal-title":"Drug Des. Dev. Therapy"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Vicens, J., Harrowfield, J., and Baklouti, L. (2007). Amino-acid, Peptide and Protein Sensing. Calixarenes in the Nanoworld, Springer.","DOI":"10.1007\/978-1-4020-5022-4"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fchem.2018.00210","article-title":"Synthesis, in-Vitro and in Silico Studies of Azo-Based Calix[4]arenes as Antibacterial Agent and Neuraminidase Inhibitor: A New Look Into an Old Scaffold","volume":"6","author":"Ali","year":"2018","journal-title":"Front. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"438946","DOI":"10.1155\/2008\/438946","article-title":"Evaluation of the Effect of Azo Group on the Biological Activity of 1-(4-Methylphenylazo)-2-naphthol","volume":"5","author":"Mkpenie","year":"2008","journal-title":"J. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"26182","DOI":"10.1021\/acsomega.0c03773","article-title":"Design and Synthesis of a New Class of Pyridine-Based N-Sulfonamides Exhibiting Antiviral, Antimicrobial, and Enzyme Inhibition Characteristics","volume":"5","author":"Azzam","year":"2020","journal-title":"ACS Omega"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"11313","DOI":"10.1128\/JVI.78.20.11313-11320.2004","article-title":"Coxsackievirus B4-Induced Cytokine Production in Pancreatic Cells Is Mediated through Toll-Like Receptor 4","volume":"78","author":"Triantafilou","year":"2004","journal-title":"J. Virol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.antiviral.2006.12.001","article-title":"Antiviral treatment of Coxsackie B virus infection in human pancreatic islets","volume":"74","author":"Berg","year":"2007","journal-title":"Antivir. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"S2280","DOI":"10.21037\/jtd.2018.03.168","article-title":"Vaccine development for human mastadenovirus","volume":"10","author":"Chen","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"30023","DOI":"10.1021\/acsomega.0c04424","article-title":"Novel Synthesis and Antiviral Evaluation of New Benzothiazole-Bearing N-Sulfonamide 2-Pyridone Derivatives as USP7 Enzyme Inhibitors","volume":"5","author":"Azzam","year":"2020","journal-title":"ACS Omega"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1021\/acsomega.9b03706","article-title":"Efficient Synthesis and Docking Studies of Novel Benzothiazole-Based Pyrimidinesulfonamide Scaffolds as New Antiviral Agents and Hsp90\u03b1 Inhibitors","volume":"5","author":"Azzam","year":"2020","journal-title":"ACS Omega"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bioorg.2015.07.005","article-title":"Synthesis and molecular modelling studies of novel sulphonamide derivatives as dengue virus 2 protease inhibitors","volume":"62","author":"Timiri","year":"2015","journal-title":"Bioorg. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Abdelnabi, R., Geraets, J.A., Ma, Y., Mirabelli, C., Flatt, J.W., Domanska, A., Delang, L., Jochmans, D., Kumar, T.A., and Jayaprakash, V. (2019). A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses. PLoS Biol., 17.","DOI":"10.1371\/journal.pbio.3000281"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Shetnev, A.A., Volobueva, A.S., Panova, V.A., Zarubaev, V.V., and Baykov, S.V. (2022). Design of 4-Substituted Sulfonamidobenzoic Acid Derivatives Targeting Coxsackievirus B3. Life, 12.","DOI":"10.3390\/life12111832"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/1\/51\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:45:25Z","timestamp":1760147125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/1\/51"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["molecules28010051"],"URL":"https:\/\/doi.org\/10.3390\/molecules28010051","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]}}}